Patents Assigned to Theracarb Inc.
  • Synthetic anti-oligosaccharide based vaccines
    Patent number: 7722890
    Abstract: The present invention provides methods of making and using immunogenic oligosaccharide compositions comprising native O-linked and S-linked oligosaccharides coupled to a protein carrier, wherein the resultant conjugate elicits a protectively immunogenic response. These compositions may be useful in vaccines against pathogenic Candida species.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: May 25, 2010
    Assignee: Theracarb, Inc.
    Inventors: David R. Bundle, Mark Nitz, Jim E. Cutler
  • Multivalent inhibitors of serum amyloid P component
    Patent number: 7553819
    Abstract: Novel glycerol cyclic pyruvate derivates were prepared and demonstrated to inhibit the binding of an immobilized D-proline derivative to serum amyloid P component (SAP) have been prepared. As such, the compounds of the invention are useful for treating amyloidosis and diseases associated with amyloidosis, for example Alzheimer&supl;s disease and maturity onset diabetes mellitus.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: June 30, 2009
    Assignee: Theracarb Inc.
    Inventors: David Bundle, Pavel Kitov, Kenneth Kai-Sing Ng, Jason Gay Shuen Ho